Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today
Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:811

Clinuvel Pharmaceuticals Limited (CUV) - Financial and Strategic SWOT Analysis Review

Clinuvel Pharmaceuticals Limited (CUV) - Financial and Strategic SWOT Analysis Review

Double click on above image to view full picture

Zoom Out
Zoom In
Additional Information
Price $125.00
Meta Description Clinuvel Pharmaceuticals Limited (Clinuvel Pharmaceuticals), formerly EpiTan Limited, is a biopharmaceutical company. The company carries out the development of photoprotective drug called Scenesse (afamelanotide) as a preventive treatment for a range of
Publisher GlobalData
Date of Report Dec 3, 2013
Quick Overview
Summary

Clinuvel Pharmaceuticals Limited (Clinuvel Pharmaceuticals), formerly EpiTan Limited, is a biopharmaceutical company. The company carries out the development of photoprotective drug called Scenesse (afamelanotide) as a preventive treatment for a range of ultra violet (UV) and light related skin disorders. Scenesse provides skin protection against UV radiation (UVR) as it stimulates the body’s natural ability to produce melanin, the dark pigment of the skin, which is known to have photoprotective properties. The company completed the testing of Scenesse in Phase II and III trials in Europe, and the US.

This comprehensive SWOT profile of Clinuvel Pharmaceuticals Limited provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Clinuvel Pharmaceuticals Limited - Key Facts 5
Clinuvel Pharmaceuticals Limited - Key Employees 6
Clinuvel Pharmaceuticals Limited - Key Employee Biographies 7
Clinuvel Pharmaceuticals Limited - Major Products and Services 8
Clinuvel Pharmaceuticals Limited - Pharmaceutical Pipeline Products Data 9
Clinuvel Pharmaceuticals Limited, Pipeline Products by Therapy Area 9
Clinuvel Pharmaceuticals Limited, Pipeline Products by Development Phase 10
Clinuvel Pharmaceuticals Limited - Medical Equipment Pipeline Products Data 12
Clinuvel Pharmaceuticals Limited Pipeline Products by Equipment Type 12
Clinuvel Pharmaceuticals Limited Pipeline Products by Development Stage 14
Clinuvel Pharmaceuticals Limited - History 16
Clinuvel Pharmaceuticals Limited - Company Statement 19
Clinuvel Pharmaceuticals Limited - Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Section 2 – Company Analysis 21
Clinuvel Pharmaceuticals Limited - Business Description 21
Clinuvel Pharmaceuticals Limited - SWOT Analysis 22
SWOT Analysis - Overview 22
Clinuvel Pharmaceuticals Limited - Strengths 22
Strength - Orphan Drug Destination 22
Strength - Proprietary Drug - Scenesse (Afamelanotide) 22
Strength - Strong Patent Portfolio 22
Clinuvel Pharmaceuticals Limited - Weaknesses 22
Weakness - Lack of Diversified Product Pipeline 22
Weakness - Negative Profitability 23
Clinuvel Pharmaceuticals Limited - Opportunities 23
Opportunity - Strategic Alliances 23
Opportunity - Emerging Markets 23
Opportunity - Potential Australian Market 23
Clinuvel Pharmaceuticals Limited - Threats 24
Threat - Industry Consolidation 24
Threat - Competitive Pressures 24
Threat - Government Regulations 24
Clinuvel Pharmaceuticals Limited - Key Competitors 25
Section 3 – Company Financial Ratios 26
Financial Ratios - Capital Market Ratios 26
Financial Ratios - Annual Ratios 26
Performance Chart 27
Financial Performance 27
Financial Ratios - Interim Ratios 28
Financial Ratios - Ratio Charts 29
Section 4 – Company’s Lifesciences Financial Deals and Alliances 30
Clinuvel Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 30
Clinuvel Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 31
Clinuvel Pharmaceuticals Limited, Medical Equipment, Deals By Year, 2007 to YTD 2013 32
Clinuvel Pharmaceuticals Limited, Medical Equipment, Deals By Type, 2007 to YTD 2013 33
Clinuvel Pharmaceuticals Limited, Recent Deals Summary 34
Section 5 – Appendix 35
Methodology 35
Ratio Definitions 35
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Clinuvel Pharmaceuticals Limited, Key Facts 5
Clinuvel Pharmaceuticals Limited, Key Employees 6
Clinuvel Pharmaceuticals Limited, Key Employee Biographies 7
Clinuvel Pharmaceuticals Limited, Major Products and Services 8
Clinuvel Pharmaceuticals Limited, Number of Pipeline Products by Therapy Area 9
Clinuvel Pharmaceuticals Limited, Number of Pipeline Products by Development Stage 10
Clinuvel Pharmaceuticals Limited, Pipeline Products By Therapy Area and Development Phase 11
Clinuvel Pharmaceuticals Limited Number of Pipeline Products by Equipment Type 12
Clinuvel Pharmaceuticals Limited Pipeline Products by Equipment Type 13
Clinuvel Pharmaceuticals Limited Number of Pipeline Products by Development Stage 14
Clinuvel Pharmaceuticals Limited Pipeline Products by Development Stage 15
Clinuvel Pharmaceuticals Limited, History 16
Clinuvel Pharmaceuticals Limited, Subsidiaries 20
Clinuvel Pharmaceuticals Limited, Key Competitors 25
Clinuvel Pharmaceuticals Limited, Ratios based on current share price 26
Clinuvel Pharmaceuticals Limited, Annual Ratios 26
Clinuvel Pharmaceuticals Limited, Interim Ratios 28
Clinuvel Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 30
Clinuvel Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 31
Clinuvel Pharmaceuticals Limited, Medical Equipment, Deals By Year, 2007 to YTD 2013 32
Clinuvel Pharmaceuticals Limited, Medical Equipment, Deals By Type, 2007 to YTD 2013 33
Clinuvel Pharmaceuticals Limited, Recent Deals Summary 34
Currency Codes 35
Capital Market Ratios 35
Equity Ratios 36
Profitability Ratios 36
Cost Ratios 37
Liquidity Ratios 37
Leverage Ratios 38
Efficiency Ratios 38

List of Figures
Clinuvel Pharmaceuticals Limited, Pipeline Products by Therapy Area 9
Clinuvel Pharmaceuticals Limited, Pipeline Products by Development Phase 10
Clinuvel Pharmaceuticals Limited Pipeline Products by Equipment Type 12
Clinuvel Pharmaceuticals Limited Pipeline Products by Development Stage 14
Clinuvel Pharmaceuticals Limited, Performance Chart (2008 - 2012) 27
Clinuvel Pharmaceuticals Limited, Ratio Charts 29
Clinuvel Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 30
Clinuvel Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013 31
Clinuvel Pharmaceuticals Limited, Medical Equipment, Deals By Year, 2007 to YTD 2013 32
Clinuvel Pharmaceuticals Limited, Medical Equipment, Deals by Type, 2007 to YTD 2013 33




...